Metformin Xr Teva (Metformin Hydrochloride)

Metformin Hydrochloride reduces hepatic glucose output, decreases intestinal absorption of glucose, and enhances peripheral insulin sensitivity. These actions collectively lower fasting and post‑prandial blood glucose without stimulating insulin secretion, making it effective for managing type 2 diabetes.

The dosage of Metformin XR Teva is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. The prescriber determines the appropriate strength and dosing schedule.

Metformin XR Teva is classified as pregnancy category B, indicating that animal studies have not shown risk but there are limited human data. It may be used during pregnancy only if the potential benefit justifies the potential risk. Breastfeeding mothers should consult their physician, as metformin is excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details, and any necessary import documentation.

Metformin XR provides a once‑daily extended‑release delivery, which can improve gastrointestinal tolerability and adherence compared with immediate‑release formulations that are typically taken two to three times daily. Both contain the same active ingredient and have comparable efficacy when dosed appropriately.

Store Metformin XR Teva at ambient temperature below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain product stability.

Metformin XR Teva is taken orally, usually once daily with the evening meal. Tablets should be swallowed whole with a full glass of water; they must not be split, chewed, or crushed, as this can disrupt the extended‑release mechanism.

The most serious risk is lactic acidosis, a rare but potentially fatal condition characterized by rapid breathing, muscle pain, and abdominal discomfort. Prompt medical attention is required if these symptoms occur. Other serious concerns include severe skin reactions and hepatic dysfunction.

Metformin XR Teva is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and those who have experienced lactic acidosis while on metformin. Caution is also advised for individuals with hepatic disease or significant alcohol use.